{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:52:16Z","timestamp":1762624336581},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s43032-019-00096-3","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T19:03:47Z","timestamp":1581707027000},"page":"925-934","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["NAV3, a Tumor Suppressor Gene, Is Decreased in Uterine Leiomyoma Tissue and Cells"],"prefix":"10.1007","volume":"27","author":[{"given":"Jasmine M.","family":"Aly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence D.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toral","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Britten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minnie","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Catherino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,1]]},"reference":[{"key":"96_CR1","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1073\/pnas.1215759110","volume":"110","author":"BV Varghese","year":"2013","unstructured":"Varghese BV, Koohestani F, McWilliams M, Colvin A, Gunewardena S, Kinsey WH, et al. Loss of the repressor REST in uterine fibroids promotes aberrant G protein-coupled receptor 10 expression and activates mammalian target of rapamycin pathway. Proc Natl Acad Sci. 2013;110:2187\u201392.","journal-title":"Proc Natl Acad Sci"},{"key":"96_CR2","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1002\/ijc.27424","volume":"131","author":"DN Markowski","year":"2012","unstructured":"Markowski DN, Bartnitzke S, L\u00f6ning T, Drieschner N, Helmke BM, Bullerdiek J. MED12 mutations in uterine fibroids\u2014their relationship to cytogenetic subgroups. Int J Cancer. 2012;131:1528\u201336.","journal-title":"Int J Cancer"},{"key":"96_CR3","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1067\/mob.2003.140","volume":"188","author":"WK Baek","year":"2003","unstructured":"Baek WK, Kim D, Jung N, Yi YW, Kim JM, Cha SD, et al. Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am J Obstet Gynecol. 2003;188:634\u20139.","journal-title":"Am J Obstet Gynecol"},{"key":"96_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033284","volume":"7","author":"A Navarro","year":"2012","unstructured":"Navarro A, Yin P, Monsivais D, Lin SM, Du P, Wei JJ, et al. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS One. 2012;7:e33284.","journal-title":"PLoS One"},{"key":"96_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0378-1119(02)00567-X","volume":"290","author":"JF Coy","year":"2002","unstructured":"Coy JF, Wiemann S, Bechmann I, B\u00e4chner D, Nitsch R, Kretz O, et al. Pore membrane and\/or filament interacting like protein 1 (POMFIL1) is predominantly expressed in the nervous system and encodes different protein isoforms. Gene. 2002;290:73\u201394.","journal-title":"Gene"},{"key":"96_CR6","doi-asserted-by":"publisher","first-page":"E451","DOI":"10.1002\/humu.20927","volume":"30","author":"FE Bleeker","year":"2009","unstructured":"Bleeker FE, Lamba S, Rodolfo M, Scarpa A, Leenstra S, Vandertop WP, et al. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes. Hum Mutat. 2009;30:E451\u20139.","journal-title":"Hum Mutat"},{"key":"96_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1111\/j.1600-0625.2011.01358.x","volume":"20","author":"P Maliniemi","year":"2011","unstructured":"Maliniemi P, Carlsson E, Kaukola A, Ovaska K, Niiranen K, Saksela O, et al. NAV3 copy number changes and target genes in basal and squamous cell cancers. Exp Dermatol. 2011;20:926\u201331.","journal-title":"Exp Dermatol"},{"key":"96_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/bjc.2011.553","volume":"106","author":"E Carlsson","year":"2012","unstructured":"Carlsson E, Ranki A, Sipil\u00e4 L, Karenko L, Abdel-Rahman WM, Ovaska K, et al. Potential role of a navigator gene NAV3 in colorectal cancer. Brit J Cancer. 2012;106:517.","journal-title":"Brit J Cancer"},{"key":"96_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/gcc.22019","volume":"52","author":"E Carlsson","year":"2013","unstructured":"Carlsson E, Krohn K, Ovaska K, Lindberg P, H\u00e4yry V, Maliniemi P, et al. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis. Genes Chromosom Cancer. 2013;52:191\u2013201.","journal-title":"Genes Chromosom Cancer"},{"key":"96_CR10","doi-asserted-by":"publisher","first-page":"8101","DOI":"10.1158\/0008-5472.CAN-04-0366","volume":"65","author":"L Karenko","year":"2005","unstructured":"Karenko L, Hahtola S, P\u00e4ivinen S, Karhu R, Syrj\u00e4 S, K\u00e4hk\u00f6nen M, et al. Primary cutaneous T-cell lymphomas show a deletion or translocation affecting NAV3, the human UNC-53 homologue. Cancer Res. 2005;65:8101\u201310.","journal-title":"Cancer Res"},{"key":"96_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/gcc.20513","volume":"47","author":"S Hahtola","year":"2008","unstructured":"Hahtola S, Burghart E, Puputti M, Karenko L, Abdel-Rahman WM, V\u00e4kev\u00e4 L, et al. Cutaneous T-cell lymphoma-associated lung cancers show chromosomal aberrations differing from primary lung cancer. Genes Chromosom Cancer. 2008;47:107\u201317.","journal-title":"Genes Chromosom Cancer"},{"key":"96_CR12","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.1145720","volume":"318","author":"LD Wood","year":"2007","unstructured":"Wood LD, Parsons DW, Jones S, Lin J, Sj\u00f6blom T, Leary RJ, et al. The genomic landscapes of human breast and colorectal cancers. Science. 2007;318:1108\u201313.","journal-title":"Science."},{"key":"96_CR13","doi-asserted-by":"crossref","unstructured":"Cohen-Dvashi H, Ben-Chetrit N, Russell R, Carvalho S, Lauriola M, Nisani S, et al. Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression. EMBO Mol Med. 2015;7:299\u2013314.","DOI":"10.15252\/emmm.201404134"},{"key":"96_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1002\/bies.201500090","volume":"37","author":"G Ou","year":"2015","unstructured":"Ou G, Weaver VM. Tumor-induced solid stress activates \u03b2-catenin signaling to drive malignant behavior in normal, tumor-adjacent cells. BioEssays. 2015;37:1293\u20137.","journal-title":"BioEssays."},{"key":"96_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1095\/biolreprod.108.075648","volume":"81","author":"PS Tanwar","year":"2009","unstructured":"Tanwar PS, Lee HJ, Zhang L, Zukerberg LR, Taketo MM, Rueda BR, et al. Constitutive activation of Beta-catenin in uterine stroma and smooth muscle leads to the development of mesenchymal tumors in mice. Biol Reprod. 2009;81:545\u201352.","journal-title":"Biol Reprod"},{"key":"96_CR16","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1111\/j.1742-4658.2008.06677.x","volume":"275","author":"LW Cheung","year":"2008","unstructured":"Cheung LW, Wong AS. Gonadotropin-releasing hormone: GnRH receptor signaling in extrapituitary tissues. FEBS J. 2008;275:5479\u201395.","journal-title":"FEBS J"},{"key":"96_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1139\/y00-096","volume":"78","author":"KW Cheng","year":"2000","unstructured":"Cheng KW, Leung PC. The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor. Can J Physiol Pharmacol. 2000;78:1029\u201352.","journal-title":"Can J Physiol Pharmacol"},{"key":"96_CR18","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.fertnstert.2012.07.1123","volume":"98","author":"JL Britten","year":"2012","unstructured":"Britten JL, Malik M, Levy G, Mendoza M, Catherino WH. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production. Fertil Steril. 2012;98:1299\u2013307.","journal-title":"Fertil Steril"},{"key":"96_CR19","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0015-0282(16)55138-3","volume":"58","author":"Y Watanabe","year":"1992","unstructured":"Watanabe Y, Nakamura G, Matsuguchi H, Nozaki M, Sano M, Nakano H. Efficacy of a low-dose leuprolide acetate depot in the treatment of uterine leiomyomata in Japanese women. Fertil Steril. 1992;58:66\u201371.","journal-title":"Fertil Steril"},{"key":"96_CR20","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/humrep\/13.6.1660","volume":"13","author":"RE Felberbaum","year":"1998","unstructured":"Felberbaum RE, Germer U, Ludwig M, Riethm\u00fcller-Winzen H, Heise S, Buttge I, et al. Treatment of uterine fibroids with a slow-release formulation of the gonadotrophin releasing hormone antagonist Cetrorelix. Hum Reprod. 1998;13:1660\u20138.","journal-title":"Hum Reprod"},{"key":"96_CR21","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejogrb.2006.07.018","volume":"134","author":"JB Engel","year":"2007","unstructured":"Engel JB, Audebert A, Frydman R, Zivny J, Diedrich K. Presurgical short term treatment of uterine fibroids with different doses of cetrorelix acetate: a double-blind, placebo-controlled multicenter study. Eur J Obstet Gynecol Reprod Biol. 2007;134:225\u201332.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"96_CR22","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1097\/AOG.0b013e3181705d0e","volume":"111","author":"ED Levens","year":"2008","unstructured":"Levens ED, Potlog-Nahari C, Armstrong AY, Wesley R, Premkumar A, Blithe DL, et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol. 2008;111:1129\u201336.","journal-title":"Obstet Gynecol"},{"key":"96_CR23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.fertnstert.2010.09.059","volume":"95","author":"LK Nieman","year":"2011","unstructured":"Nieman LK, Blocker W, Nansel T, Mahoney S, Reynolds J, Blithe D, et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. Fertil Steril. 2011;95:767\u201372.","journal-title":"Fertil Steril"},{"key":"96_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW. A new mathematical model for relative quantification in real-time RT\u2013PCR. Nucleic Acids Res. 2001;29:e45.","journal-title":"Nucleic Acids Res"},{"key":"96_CR25","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1016\/j.fertnstert.2014.01.017","volume":"101","author":"M Ono","year":"2014","unstructured":"Ono M, Yin P, Navarro A, Moravek MB, Druschitz SA, Gottardi CJ, et al. Inhibition of canonical WNT signaling attenuates human leiomyoma cell growth. Fertil Steril. 2014;101:1441\u20139.","journal-title":"Fertil Steril"},{"key":"96_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1046\/j.1365-2265.2002.01291.x","volume":"56","author":"LA Kiesel","year":"2002","unstructured":"Kiesel LA, Rody A, Greb RR, Szilagyi A. Clinical use of GnRH analogues. Clin Endocrinol. 2002;56:677\u201387.","journal-title":"Clin Endocrinol"},{"key":"96_CR27","doi-asserted-by":"publisher","first-page":"4663","DOI":"10.1210\/endo.142.11.8503","volume":"142","author":"HM Everest","year":"2001","unstructured":"Everest HM, Hislop JN, Harding T, Uney JB, Flynn A, Millar RP, et al. Signaling and antiproliferative effects mediated by GnRH receptors after expression in breast cancer cells using recombinant adenovirus. Endocrinol. 2001;142:4663\u201372.","journal-title":"Endocrinol"},{"key":"96_CR28","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1530\/eje.0.1450651","volume":"145","author":"C Grundker","year":"2001","unstructured":"Grundker C, Schlotawa L, Viereck V, Emons G. Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin. Eur J Endocrinol. 2001;145:651\u20138.","journal-title":"Eur J Endocrinol"},{"key":"96_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0188-4409(01)00331-9","volume":"32","author":"S Kraus","year":"2001","unstructured":"Kraus S, Naor Z, Seger R. Intracellular signaling pathways mediated by the gonadotropin-releasing hormone (GnRH) receptor. Arch Med Res. 2001;32:499\u2013509.","journal-title":"Arch Med Res"},{"key":"96_CR30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1677\/erc.0.0100169","volume":"10","author":"SK Kang","year":"2003","unstructured":"Kang SK, Choi KC, Yang HS, Leung PC. Potential role of gonadotrophin-releasing hormone (GnRH)-I and GnRH-II in the ovary and ovarian cancer. Endocr Relat Cancer. 2003;10:169\u201377.","journal-title":"Endocr Relat Cancer"},{"key":"96_CR31","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0024-3205(98)00173-8","volume":"62","author":"H Yin","year":"1998","unstructured":"Yin H, Cheng KW, Hwa HL, Peng C, Auersperg N, Leung PC. Expression of the messenger RNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines. Life Sci. 1998;62:2015\u201323.","journal-title":"Life Sci"},{"key":"96_CR32","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/0006-291X(92)91556-6","volume":"189","author":"SS Kakar","year":"1992","unstructured":"Kakar SS, Musgrove LC, Devor DC, Sellers JC, Neill JD. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun. 1992;189:289\u201395.","journal-title":"Biochem Biophys Res Commun"},{"key":"96_CR33","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1002\/1097-0142(19941101)74:9<2555::AID-CNCR2820740925>3.0.CO;2-X","volume":"74","author":"A Imai","year":"1994","unstructured":"Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T. Gonadotropin-releasing hormone receptor in gynecologic tumors. Frequent expression in adenocarcinoma histologic types. Cancer. 1994;74:2555\u201361.","journal-title":"Cancer."},{"key":"96_CR34","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1006\/gyno.1994.1264","volume":"55","author":"A Imai","year":"1994","unstructured":"Imai A, Ohno T, Iida K, Fuseya T, Furui T, Tamaya T. Presence of gonadotropin-releasing hormone receptor and its messenger ribonucleic acid in endometrial carcinoma and endometrium. Gynecol Oncol. 1994;55:144\u20138.","journal-title":"Gynecol Oncol"},{"key":"96_CR35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1177\/000456329403100604","volume":"31","author":"A Imai","year":"1994","unstructured":"Imai A, Ohno T, Ohsuye K, Tamaya T. Expression of gonadotropin-releasing hormone receptor in human epithelial ovarian carcinoma. Ann Clin Biochem. 1994;31:550\u20135.","journal-title":"Ann Clin Biochem"},{"key":"96_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.2147\/DHPS.S24106","volume":"3","author":"S Choi","year":"2011","unstructured":"Choi S, Lee AK. Efficacy and safety of gonadotropin-releasing hormone agonists used in the treatment of prostate cancer. Drug Healthc Patient Saf. 2011;3:107\u201319.","journal-title":"Drug Healthc Patient Saf"},{"issue":"13","key":"96_CR37","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/dneu.20670","volume":"68","author":"PD Muley","year":"2008","unstructured":"Muley PD, McNeill EM, Marzinke MA, Knobel KM, Barr MM, Clagett-Dame M. The atRA-responsive gene neuron navigator 2 functions in neurite outgrowth and axonal elongation. Develop Neurobiol. 2008;68(13):1441\u201353.","journal-title":"Develop Neurobiol"},{"issue":"4","key":"96_CR38","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1242\/dev.016816","volume":"136","author":"KL Schmidt","year":"2009","unstructured":"Schmidt KL, Marcus-Gueret N, Adeleye A, Webber J, Baillie D, Stringham EG. The cell migration molecule UNC-53\/NAV2 is linked to the ARP2\/3 complex by ABI-1. Development. 2009;136(4):563\u201374.","journal-title":"Development."},{"issue":"14","key":"96_CR39","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1242\/dev.129.14.3367","volume":"129","author":"E Stringham","year":"2002","unstructured":"Stringham E, Pujol N, Vandekerckhove J, Bogaert T. unc-53 controls longitudinal migration in C. elegans. Development. 2002;129(14):3367\u201379.","journal-title":"Development."},{"issue":"7","key":"96_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ncb1739","volume":"10","author":"Y Nakaya","year":"2008","unstructured":"Nakaya Y, Sukowati EW, Wu Y, Sheng G. RhoA and microtubule dynamics control cell\u2013basement membrane interaction in EMT during gastrulation. Nat Cell Biol. 2008;10(7):765.","journal-title":"Nat Cell Biol"},{"key":"96_CR41","doi-asserted-by":"crossref","unstructured":"Norian JM, Owen CM, Taboas J, Korecki C, Tuan R, Malik M, et al. Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biol. 31(1):57\u201365.","DOI":"10.1016\/j.matbio.2011.09.001"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s43032-019-00096-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-019-00096-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,15]],"date-time":"2022-10-15T17:02:16Z","timestamp":1665853336000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s43032-019-00096-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s43032-019-00096-3","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}